Skin Cancer

Oncology·MeSH: Skin Neoplasms

7 drugs in development·3 companies·19 clinical trials

Drug Pipeline by Phase

Approved(3)

Phase 3(1)

Drug	Company
chemotherapy	HERON THERAPEUTICS, INC. /DE/ (HRTX)

Phase 2(1)

Drug	Company
Lifileucel	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Phase 2/Phase 3(2)

Drug	Company
immunotherapy	HERON THERAPEUTICS, INC. /DE/ (HRTX)
lns8801	HERON THERAPEUTICS, INC. /DE/ (HRTX)

BioSniper tracks 7 drugs in development for Skin Cancer across 3 companies.

There are 19 clinical trials targeting Skin Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.